StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3025% above fair value
$1410.99−6.55 (-0.46%)

Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%

Eli Lilly Cymbalta (duloxetine) by Quarter

Cymbalta (duloxetine) — Worldwide revenue YoY (%) [legacy] (%)

QuarterlyAnnual

Eli Lilly Cymbalta (duloxetine): -53.0% in Q3 2022, down 24.0 pts from a year earlier. No newer figure appears in the documents we track.

Latest, Q3 2022
-53.0%
Period ended Sep 30, 2022
Change on a year earlier
-24.0 pts
-29.0% in Q3 2021
History
15 quarters
Since Q1 2018
Sources
15
Documents cited below

Where the Q3 2022 figure comes from

“|| Cymbalta | 7.8 | 54.9 | 62.7 | 132.0 | (53)”

Source: Form 10-Q FY2022Q3 (filed 2022-11-01) ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCymbalta (duloxetine) — Worldwide revenue YoY (%) [legacy] (%)Year on yearSource
Q3 2022Sep 30, 2022-53.0%-24.0 ptsForm 10-Q FY2022Q3 (filed 2022-11-01) ↗
Q2 2022Jun 30, 2022-57.0%-55.0 ptsForm 10-Q FY2022Q2 (filed 2022-08-04) ↗
Q1 2022Mar 31, 2022-54.0%-38.0 ptsForm 10-Q FY2022Q1 (filed 2022-04-29) ↗
Q3 2021Sep 30, 2021-29.0%-34.0 ptsForm 10-Q FY2021Q3 (filed 2021-10-27) ↗
Q2 2021Jun 30, 2021-2.0%+2.0 ptsForm 10-Q FY2021Q2 (filed 2021-08-03) ↗
Q1 2021Mar 31, 2021-16.0%-44.0 ptsForm 10-Q FY2021Q1 (filed 2021-04-30) ↗
Q3 2020Sep 30, 20205.0%+1.0 ptsForm 10-Q FY2020Q3 (filed 2020-10-28) ↗
Q2 2020Jun 30, 2020-4.0%-7.0 ptsForm 10-Q FY2020Q2 (filed 2020-07-31) ↗
Q1 2020Mar 31, 202028.0%+31.0 ptsForm 10-Q FY2020Q1 (filed 2020-05-01) ↗
Q3 2019Sep 30, 20194.0%+10.0 ptsForm 10-Q FY2019Q3 (filed 2019-10-25) ↗
Q2 2019Jun 30, 20193.0%+15.0 ptsForm 10-Q FY2019Q2 (filed 2019-08-02) ↗
Q1 2019Mar 31, 2019-3.0%0.0 ptsForm 10-Q FY2019Q1 (filed 2019-05-02) ↗
Q3 2018Sep 30, 2018-6.0%–Form 10-Q FY2018Q3 (filed 2018-11-06) ↗
Q2 2018Jun 30, 2018-12.0%–Form 10-Q FY2018Q2 (filed 2018-07-25) ↗
Q1 2018Mar 31, 2018-3.0%–Form 10-Q FY2018Q1 (filed 2018-04-27) ↗

Cite this data

StockData. (2026). Eli Lilly Cymbalta (duloxetine) (%), quarterly Q1 2018–Q3 2022 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/med-cymbalta-yoy

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.